Gain Therapeutics, Inc. (GANX)

Gain Therapeutics Statistics

Total Valuation

GANX has a market cap or net worth of $74.64 million. The enterprise value is $60.06 million.

Market Cap	74.64M
Enterprise Value	60.06M

Important Dates

The last earnings date was Monday, May 11, 2026, before market open.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

GANX has 42.65 million shares outstanding. The number of shares has increased by 42.24% in one year.

Current Share Class	42.65M
Shares Outstanding	42.65M
Shares Change (YoY)	+42.24%
Shares Change (QoQ)	+11.66%
Owned by Insiders (%)	2.36%
Owned by Institutions (%)	19.73%
Float	41.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.40
P/TBV Ratio	5.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.69, with a Debt / Equity ratio of 0.05.

Current Ratio	4.69
Quick Ratio	4.31
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -214.69% and return on invested capital (ROIC) is -116.98%.

Return on Equity (ROE)	-214.69%
Return on Assets (ROA)	-81.17%
Return on Invested Capital (ROIC)	-116.98%
Return on Capital Employed (ROCE)	-132.74%
Weighted Average Cost of Capital (WACC)	5.06%
Revenue Per Employee	n/a
Profits Per Employee	-$1.01M
Employee Count	21
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, GANX has paid $943,675 in taxes.

Income Tax	943,675
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.91% in the last 52 weeks. The beta is 0.15, so GANX's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	-5.91%
50-Day Moving Average	2.04
200-Day Moving Average	2.19
Relative Strength Index (RSI)	39.89
Average Volume (20 Days)	486,429

Short Selling Information

The latest short interest is 3.44 million, so 8.07% of the outstanding shares have been sold short.

Short Interest	3.44M
Short Previous Month	3.33M
Short % of Shares Out	8.07%
Short % of Float	8.27%
Short Ratio (days to cover)	6.24

Income Statement

Revenue	n/a
Gross Profit	-10.07M
Operating Income	-19.72M
Pretax Income	-20.30M
Net Income	-21.24M
EBITDA	-19.67M
EBIT	-19.72M
Earnings Per Share (EPS)	-$0.58

Balance Sheet

The company has $16.54 million in cash and $672,302 in debt, with a net cash position of $15.87 million or $0.37 per share.

Cash & Cash Equivalents	16.54M
Total Debt	672,302
Net Cash	15.87M
Net Cash Per Share	$0.37
Equity (Book Value)	14.01M
Book Value Per Share	0.33
Working Capital	14.34M

Cash Flow

Operating Cash Flow	-19.37M
Capital Expenditures	n/a
Depreciation & Amortization	45,689
Net Borrowing	-99,784
Free Cash Flow	-19.37M
FCF Per Share	-$0.45

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GANX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-42.24%
Shareholder Yield	-42.24%
Earnings Yield	-27.97%
FCF Yield	-25.51%

Analyst Forecast

The average price target for GANX is $7.50, which is 328.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.50
Price Target Difference	328.57%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3